Pacifica Partners’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $16.6K | Hold |
200
| – | – | 0.01% | 298 |
|
2025
Q1 | $15.6K | Hold |
200
| – | – | 0.01% | 301 |
|
2024
Q4 | $18.3K | Hold |
200
| – | – | 0.01% | 298 |
|
2024
Q3 | $19.8K | Hold |
200
| – | – | 0.01% | 299 |
|
2024
Q2 | $18.2K | Hold |
200
| – | – | 0.01% | 314 |
|
2024
Q1 | $18.5K | Hold |
200
| – | – | 0.01% | 302 |
|
2023
Q4 | $15.8K | Hold |
200
| – | – | 0.01% | 323 |
|
2023
Q3 | $14.4K | Hold |
200
| – | – | 0.01% | 314 |
|
2023
Q2 | $16.6K | Hold |
200
| – | – | 0.01% | 256 |
|
2023
Q1 | $15.3K | Hold |
200
| – | – | 0.01% | 268 |
|
2022
Q4 | $15.7K | Hold |
200
| – | – | 0.01% | 246 |
|
2022
Q3 | $16K | Hold |
200
| – | – | 0.01% | 258 |
|
2022
Q2 | $15K | Hold |
200
| – | – | 0.01% | 274 |
|
2022
Q1 | $18K | Hold |
200
| – | – | 0.01% | 260 |
|
2021
Q4 | $21K | Hold |
200
| – | – | 0.01% | 244 |
|
2021
Q3 | $26K | Buy |
200
+150
| +300% | +$19.5K | 0.02% | 209 |
|
2021
Q2 | $7K | Hold |
50
| – | – | 0.01% | 328 |
|
2021
Q1 | $7K | Sell |
50
-50
| -50% | -$7K | 0.01% | 306 |
|
2020
Q4 | $15K | Buy |
+100
| New | +$15K | 0.01% | 213 |
|